Analysis of Transplant-Eligible Patients (Pts) Who Received Frontline Daratumumab (DARA)-Based Quadruplet Therapy for the Treatment of Newly Diagnosed Multiple Myeloma (NDMM) with High-Risk Cytogenetic Abnormalities (HRCA) in the Griffin and Master Studies
Year: 2022
Type: article
Source: Blood
Authors: Natalie Callander, Rebecca Silbermann, Jonathan L. Kaufman, Kelly N. Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D. Anderson, Bhagirathbhai Dholaria, Nitya Nathwani, Parameswaran Hari, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Ken H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Smith Giri, Luciano J. Costa, Paul G. Richardson, Saad Usmani, Peter M. Voorhees
Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Oregon Health & Science University, OHSU Knight Cancer Institute, Emory University, Winship Cancer Institute, University of Alabama at Birmingham Hospital, University of Alabama at Birmingham, Harvard University, Dana-Farber Cancer Institute, University of Utah, Huntsman Cancer Institute, University of North Carolina at Chapel Hill, Medical College of Wisconsin, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Vanderbilt University, Vanderbilt University Medical Center, City Of Hope National Medical Center, City of Hope, University of California, San Francisco, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, University of Nebraska Medical Center, University of California San Diego, University of Chicago, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, University of Washington, Janssen Scientific Affairs (United States), UAB Medicine, Memorial Sloan Kettering Cancer Center, Atrium Health Wake Forest Baptist, Levine Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310093508